SMMT — Summit Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapMomentum Trap

Annual balance sheet for Summit Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	66.4	71.8	349	186	412
Net Total Accounts Receivable
Net Total Receivables	10.2	17.2	6.12	0.848	0.557
Prepaid Expenses
Total Other Current Assets
Total Current Assets	87.7	97.3	657	190	424
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.28	3.48	5.08	6.06	7.4
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	102	113	664	203	436
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	19.9	25.6	38.8	20.4	41.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23	30.1	538	125	46.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	79.5	83.3	127	77.7	389
Total Liabilities & Shareholders' Equity	102	113	664	203	436
Total Common Shares Outstanding